[conteúdo em construção]
Anticoncepcionais e a falha em suprimir a ovulação
- Killick S, Eyong E, Elstein M. Ovarian follicular development in oral contraceptive cycles. Fertil Steril. 1987;48:409–13 pubmed
- (2) Hamilton CJ, Hoogland HJ. Longitudinal ultrasonographic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect pill intake. Am J Obstet Gynecol. 1989;161:1159–62 pubmed
- (3) Young RL, Snabes MC, Frank ML, Reilly M. A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development. Am J Obstet Gynecol. 1992;167:678–82 pubmed
- (4) Broome M, Clayton J, Fotherby K. Enlarged follicles in women using oral contraceptives. Contraception. 1995;52:13–6 pubmed
- (5) Teichmann AT, Brill K, Albring M, Schnitker J, Wojtynek P, Kustra E. The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth. Gynecol Endocrinol. 1995;9:299–305 pubmed
- (6) Coney P, DelConte A. The effects on ovarian activity of a monophasic oral contraceptive with 100 microg levonorgestrel and 20 microg ethinyl estradiol. Am J Obstet Gynecol. 1999;181:53–8 pubmed
- (7) Pierson R, Archer D, Moreau M, Shangold G, Fisher A, Creasy G, et al. SGiA: Ortho EVRA™ vs oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error. Fertil Steril. 2003;80(1):34–42 pubmed
- (8) London A, Jensen JT. Rationale for eliminating the hormone-free interval in modern oral contraceptives. Int J Gynaecol Obstet. 2016;134(1):8-12 pubmed
- (9) Van Heusden AM, Fauser BC. Residual ovarian activity during oral steroid contraception. Hum Reprod Update. 2002;8:345–58 pubmed
Autonomia do embrião
- Shahbazi MN, Jedrusik A, Vuoristo S, Recher G, Hupalowska A, Bolton V, Fogarty NNM, Campbell A, Devito L, Ilic D, Khalaf Y, Niakan KK, Fishel S, Zernicka-Goetz M. 2016. Self-organization of the human embryo in the absence of maternal tissues. Nat Cell Biol. Jun;18(6):700-708 pubmed
Mecanismos de ação do DIU
Prejuízo na implantação:
1. Stanford JB, Mikolajczyk RT. 2002. Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am J Obstet Gynecol. Dec;187(6):1699-708. pubmed
2. ESHRE Capri Workshop Group. 2008. Intrauterine devices and intrauterine systems. Hum Reprod Update. May-Jun;14(3):197-208. pubmed
2. Savaris R1, Zettler CG, Ferrari AN. 2000. Expression of alpha4beta1 and alphavbeta3 integrins in the endometrium of women using the T200 copper intrauterine device. Fertil Steril. Dec;74(6):1102-7. pubmed